Literature DB >> 29895576

Central nervous system blast crisis of chronic myeloid leukaemia misdiagnosed as tubercular meningitis.

Banshi Lal Kumawat1, Chandra Mohan Sharma1, Pankaj Kumar Saini1, Ankur Garg1.   

Abstract

Chronic Myeloid Leukaemia (CML) presenting with isolated Central Nervous System (CNS) blast crisis is an uncommon entity. A 22-year-old man, diagnosed with chronic phase CML in 2011 and was in haematological and cytogenetic remission until July 2016, had acute onset headache and vomiting with meningeal signs and was admitted elsewhere, investigated by brain imaging and cerebrospinal fluid (CSF) analysis and suspected to have tubercular meningitis, for which steroids and antitubercular medications were started. The patient's sensorium further deteriorated, and Ventriculoperitoneal shunt surgery was done for hydrocephalus by a neurosurgeon. After 2 months of the illness, he was admitted to our hospital with a persistent headache, vomiting and altered sensorium. CSF for cytospin confirmed myeloid blasts. He was still in haematological remission. So, a diagnosis of isolated CNS blast crisis was made. The patient was started on triple intrathecal chemotherapy and cranial radiotherapy. He had improvement with treatment and is still in remission. © BMJ Publishing Group Ltd (unless otherwise stated in the text of the article) 2018. All rights reserved. No commercial use is permitted unless otherwise expressly granted.

Entities:  

Keywords:  haematology (incl blood transfusion); neurology (drugs and medicines)

Mesh:

Substances:

Year:  2018        PMID: 29895576      PMCID: PMC6011440          DOI: 10.1136/bcr-2017-223923

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  9 in total

1.  Isolated central nervous system relapse in two patients with BCR-ABL-positive acute leukemia while receiving a next-generation tyrosine kinase inhibitor.

Authors:  Sumit Gaur; Ali-Reza Torabi; Javier Corral
Journal:  In Vivo       Date:  2014 Nov-Dec       Impact factor: 2.155

2.  Imatinib mesylate--the new gold standard for treatment of chronic myeloid leukemia.

Authors:  Karl Peggs; Stephen Mackinnon
Journal:  N Engl J Med       Date:  2003-03-13       Impact factor: 91.245

3.  Fluorescent in situ hybridization diagnosis of extramedullary nodal blast crisis.

Authors:  Guan-Nan Jin; Ping Zou; Wan-Xin Chen; Ze-Yang Ding; Hao Zhou
Journal:  Diagn Cytopathol       Date:  2011-08-26       Impact factor: 1.582

4.  Isolated central nervous system blast crisis in chronic myeloid leukemia.

Authors:  Senthil Rajappa; Shantveer G Uppin; D Raghunadharao; I Satish Rao; Anjna Surath
Journal:  Hematol Oncol       Date:  2004-12       Impact factor: 5.271

5.  Letter: A new consistent chromosomal abnormality in chronic myelogenous leukaemia identified by quinacrine fluorescence and Giemsa staining.

Authors:  J D Rowley
Journal:  Nature       Date:  1973-06-01       Impact factor: 49.962

6.  How I treat CML blast crisis.

Authors:  Rüdiger Hehlmann
Journal:  Blood       Date:  2012-05-31       Impact factor: 22.113

7.  High incidence of meningeal leukemia in lymphoid blast crisis of chronic myelogenous leukemia.

Authors:  T K Saikia; B Dhabhar; R S Iyer; G Nanjangud; R Gopal; C N Nair; K S Nadkarni; M S Ashokkumar; S R Dhond; S H Advani
Journal:  Am J Hematol       Date:  1993-05       Impact factor: 10.047

8.  Imatinib mesylate has limited activity against the central nervous system involvement of Philadelphia chromosome-positive acute lymphoblastic leukaemia due to poor penetration into cerebrospinal fluid.

Authors:  Nobuyuki Takayama; Norihide Sato; Stephen G O'Brien; Yasuo Ikeda; Shin-Ichiro Okamoto
Journal:  Br J Haematol       Date:  2002-10       Impact factor: 6.998

9.  Central nervous system blastic crisis in chronic myeloid leukemia on imatinib mesylate therapy: a case report.

Authors:  Abdullah Altintas; Timucin Cil; Ilhan Kilinc; Muhammet Ali Kaplan; Orhan Ayyildiz
Journal:  J Neurooncol       Date:  2007-02-23       Impact factor: 4.506

  9 in total
  1 in total

1.  Chronic Myeloid Leukemia Presenting with Fleeting Facial Nerve Palsy.

Authors:  Rajeev Sandal; Parikshaa Gupta; Aditya Jandial; Kundan Mishra; Deepesh Lad; Shano Naseem; Gaurav Prakash; Alka Khadwal; Pankaj Malhotra
Journal:  Indian J Hematol Blood Transfus       Date:  2019-01-29       Impact factor: 0.900

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.